Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Emerging Infectious Diseases|July 13, 2019
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, BrazilAna Carolina Campi-Azevedo, Vanessa Peruhype-Magalhāes, Jordana Grazziela Coelho-Dos-Reis, et al.
Plos One|December 20, 2012
17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated childrenAna Carolina Campi-Azevedo, Luiza Pacheco de Araújo-Porto, Maria Luiza-Silva, et al.
BMC Infectious Diseases|July 16, 2014
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timelineAna Carolina Campi-Azevedo, Paula de Almeida Estevam, Jordana Grazziela Coelho-Dos-Reis, et al.
Frontiers in Immunology|July 12, 2019
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever VaccineIsmael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Frontiers in Immunology|November 8, 2019
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever VaccineIsmael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Frontiers in Immunology|October 17, 2019
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in ChildrenAna Carolina Campi-Azevedo, Laise Rodrigues Reis, Vanessa Peruhype-Magalhães, et al.
Plos Neglected Tropical Diseases|June 8, 2018
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccinationChristiane Costa-Pereira, Ana Carolina Campi-Azevedo, Jordana Grazziela Coelho-Dos-Reis, et al.
Vaccine|December 31, 2021
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever VirusLaise Rodrigues Reis, Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, et al.
The Journal of Experimental Medicine|February 5, 2021
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccinePaul Bastard, Eleftherios Michailidis, Hans-Heinrich Hoffmann, et al.
The Journal of Experimental Medicine|July 5, 2019
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccinesNicholas Hernandez, Giorgia Bucciol, Leen Moens, et al.
Pageof 9